Hrt Financial LP Intercept Pharmaceuticals, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $1.12 Million - $1.81 Million	91,644 Added 209.26%	135,438 $1.89 Million
Q2 2022 Aug 12, 2022	BUY	$11.23 - $19.59 $75,678 - $132,017	6,739 Added 18.19%	43,794 $604,000
Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $872,646 - $1.16 Million	-65,269 Reduced 63.79%	37,055 $602,000
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $738,047 - $1.01 Million	51,684 Added 102.06%	102,324 $1.67 Million
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $657,813 - $1.04 Million	50,640 New	50,640 $752,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.